动脉粥样硬化斑块核素显像研究进展

万建美; 范我

动脉粥样硬化斑块核素显像研究进展

万建美 , 范我

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 1: (17-20)

引用本文:

Citation:

动脉粥样硬化斑块核素显像研究进展

万建美,
范我^,

215123 苏州, 苏州大学放射医学与公共卫生学院基础核医学教研室

通讯作者: 范我, fanwo@publicl.sz.js.cn

中图分类号: R543.5;R817

The progress of research on atherosclerotic plaque nuclear imaging

WAN Jian-mei,
FAN Wo^,

Department of Basic Nuclear Medicine, School of Radiation Medicine and Public Health, Soochow University, Suzhou 215123, China

Corresponding author: FAN Wo, fanwo@publicl.sz.js.cn

CLC number: R543.5;R817

摘要: 核素显像是一种较为理想和具有广泛用途的无创伤性检查技术,是目前惟一能定性、定量反映器官组织血流、代谢及功能改变的影像学方法。利用放射性核素标记参与动脉粥样硬化的中间物质进行显像,可发现早期病变。
- 动脉粥样硬化斑块 /
- 放射性核素 /
- 显像剂
Abstract: Nuclear imaging is an ideal and useful noninvasive detection technology, is the unique imageology method reflecting the changes of tissue and organ blood flow, metabolism and function qualitatively and quantitatively. Atherosclerotic plaque nuclear imaging using the radioisotope labeled intermediate materials participating in atherosclerosis can discover the early stage lesion. This article focuses on studying the recent developments of the atherosclerosis imaging agents and assessing their clinical prospects.
- Atherosclerotic plaque /
- Radionuclide /
- Imaging agents
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Bozoky Z, Balogh L, Mathe D, et al. Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia. Eur Biophys J,2004, 33(2):140-145.
[2]	Torzewski M, Shaw PX, Han KR, et al. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.Atheroseler Thromb Vasc Biol, 2004, 24(12):2307-2312.
[3]	Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol, 2002, 90(10C):22L-27L.
[4]	Dinkelborg LM, Duda SH, Hanke H, et al. Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative. J Nucl Med, 1998, 39(10):1819-1822.
[5]
[6]	Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F (ab')₂ specifie for the proliferating smooth muscle cells of human atheroma. Circulation, 1995, 92(3):474-484.
[7]	Mitchel J, Waters D, Lai T, et al. Identification of coronary thrombus with a Ⅱb/Ⅲa platelet inhibitor radiophannaceutical,technetium-99m DMP-444:A canine model. Circulation, 2000,101(14):1643-1646.
[8]	曹卫,张永学,安锐.^99mTc-Ap4A显像探测动脉粥样硬化斑块的动物实验研究.中华核医学杂志,2001,21(6):325-328.
[9]	Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeo-xyglucose(FDG). Nucl Med Commun, 2001, 22(7):747-753.
[10]	Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotic plaques:immunohistochemical and PET imaging study. J Nucl Med, 2004, 45(7):1245-1250.
[11]	Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol, 2005, 12(3):294-301.
[12]	Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrop-hages and experimental atheroma with radiolabeled annexin V. Circulation, 2003, 108(25):3134-3139.
[13]	Matter CM, Schuler PK, Alessi P, et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extradomain B of fibronectin. Am Heart Assoc, Circ Res, 2004, 95(12):1225-1233.
[14]	Gawaz M, Konrad I, Hauer AI, et al. Non-invasive imaging of glycoprotein Ⅵ binding to injured arterial lesions. Thromb Heamost, 2005, 93(5):910-913.
[15]	Qin G, Zhang Y, Cao W, et al. Molecular imaging of atherosclerotic plaques with technetium-99m labelled antisense oligonucleotides. Eur J Nucl Med Mol Imaging, 2005, 32(1):6-14.
[16]	Amnovazzi A, Bonanno E, Arca M, et al. ^99mTc-intedeukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging, 2006, 33(2):117-126.

[1]	曹卫 , 张永学 . 动脉粥样硬化斑块核素显像研究进展. 国际放射医学核医学杂志, 1999, 23(5): 212-215.
[2]	张艳容 . 动脉粥样硬化斑块显像研究进展. 国际放射医学核医学杂志, 2004, 28(3): 109-113.
[3]	赵晋华 , 林祥通 . 抑郁症的放射性核素脑血流灌注和脑受体显像研究进展. 国际放射医学核医学杂志, 1998, 22(2): 49-51.
[4]	秦光明 . 肿瘤核素反义显像技术的研究现状与展望. 国际放射医学核医学杂志, 2001, 25(5): 213-216.
[5]	陈立波 , 朱瑞森 . NIS在肿瘤核素基因显像与治疗中的应用研究. 国际放射医学核医学杂志, 2005, 29(2): 70-73.
[6]	任均田 , 林学颜 . 放射免疫显像与治疗的应用进展. 国际放射医学核医学杂志, 1995, 19(2): 57-59.
[7]	张金山 , 蒋宁一 . 放射性血管内支架——防治冠状动脉再狭窄. 国际放射医学核医学杂志, 1999, 23(4): 162-164.
[8]	杨建权 , 李晔 , 张现忠 . 基于小分子肽的放射性药物. 国际放射医学核医学杂志, 2003, 27(4): 157-161.
[9]	曹国祥 , 谭天秩 . 多巴胺受体显像剂的研究概况. 国际放射医学核医学杂志, 1999, 23(2): 65-67.
[10]	莫纯威 , 徐万帮 , 唐刚华 . 靶向成纤维细胞活化蛋白PET显像剂的研究进展. 国际放射医学核医学杂志, 2022, 46(12): 735-741. doi: 10.3760/cma.j.cn121381-202203029-00251